Skip to main content
Figure 1 | Trials

Figure 1

From: Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial

Figure 1

Overview of the Riverleft study design. Eligible patients will be informed about the study and asked to participate. Signed informed consent will be obtained prior to enrollment. In the next phase, the participant will be randomized between right atrial appendage (RAA) pacing and distal coronary sinus (dCS) pacing. A three-month run-in time will start after implantation. Adjustments to pacemaker settings and prescribed medication can be made without any consequences for the study. After finishing the run-in period, adjustments to pacemaker (PM) settings or prescribed drugs are only allowed if necessary. Electrocardiogram (ECG) will be made at each visit, an echocardiogram et the end of each follow-up year. The study will end for each participant after a 36-month follow-up period.

Back to article page

Trials

ISSN: 1745-6215